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Background: Knee osteoarthritis is the most common type of arthritis, with pain being its most common
symptom. Little is known about the psychological aspects of knee osteoarthritis pain. There is an emerging
consensus among osteoarthritis specialists about the importance of addressing not only biological but also
psychosocial factors in the assessment and treatment of osteoarthritis. As few studies have evaluated the effect of
psychological interventions on knee osteoarthritis pain, good quality randomized controlled trials are needed to
determine their effectiveness.
Methods/Design: We intend to conduct a 6-week single-blinded randomized controlled trial with a 12-month
follow-up. Altogether, 108 patients aged from 35 to 75 years with clinical symptoms and radiographic grading
(KL 2–4) of knee osteoarthritis will be included. The clinical inclusion criteria are pain within the last year in or
around the knee occurring on most days for at least one month, and knee pain of ≥40 mm on a 100-mm visual
analogue scale in the WOMAC pain subscale for one week prior to study entry. Patients with any severe psychiatric
disorder, other back or lower limb pain symptoms more aggravating than knee pain, or previous or planned lower
extremity joint surgery will be excluded. The patients will be randomly assigned to a combined GP care and
cognitive-behavioral intervention group (n = 54) or to a GP care control group (n = 54). The cognitive-behavioral
intervention will consist of 6 weekly group sessions supervised by a psychologist and a physiotherapist experienced
in the treatment of pain. The main goals of the intervention are to reduce maladaptive pain coping and to increase
the self-management of pain and disability. The follow-up-points will be arranged at 3 and 12 months. The primary
outcome measure will be the WOMAC pain subscale. Secondary outcome measures will include self-reports of pain
and physical function, a health related quality of life questionnaire, and various psychological questionnaires.
Personnel responsible of the data analysis will be blinded.
Discussion: This study addresses the current topic of non-pharmacological conservative treatment of knee
OA-related pain. We anticipate that these results will provide important new insights to the current care
recommendations.
Trial registration: Current Controlled Trials ISRCTN64794760
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Osteoarthritis (OA) is the most common form of arth-
ritis and a major contributor to functional disability [1].
It represents a major social and health problem in the
elderly, imposing an increasingly heavy economic burden
on social welfare and health care systems. This is due to
the need for surgical and medical interventions and fre-
quent absenteeism from work [2]. Although not all OA
is symptomatic, the World Health Organization has esti-
mated that OA is the cause of disability in at least 10%
of the population over the age of 60 years [3].
Knee OA is the most common type of arthritis. The
main symptom of knee OA is pain, which is generally
related to joint use and relieved by rest. However, the
association between radiological changes in knee OA
and the severity of pain or the level of disability is not
straightforward. As OA progresses, the pain may be-
come more persistent and also manifest itself at rest. In
addition to pain, loss of function and joint stiffness are
typical symptoms of OA, which often lead to difficulties
in performing daily activities.
The assessment and treatment of pain is vital to the
management of OA [4]. It is known that chronic pain is
associated with increased considerable psychological dis-
tress, such as anxiety and depression. One population
study from 17 different countries found that depression
and anxiety disorders occurred significantly more often
in individuals with self-reported arthritis, with depres-
sion present in 5−10% of those with arthritis [5]. In
another study conducted by Smith and Zautra, measures
of anxiety and depression emerged as independent and
significant predictors of current and future pain [6].
The cognitive-behavioral (CB) perspective presented
by Turk et al. [7] is the most widely accepted model in
the field of pain psychology. It has led to the identi-
fication of cognitive and other psychological factors that
are associated with pain severity and disability. If one
considers the constructs that have the strongest em-
pirical support, factors like pain catastrophizing [8],
fear-avoidance [9], self-efficacy and lack of perceived
control [10,11], and passive pain coping [12] have been
claimed to be of importance. Factors, such as pain cata-
strophizing and pain-related fear, have been found to be
strongly and consistently associated with pain severity
and disability in patients with musculoskeletal pain [13]
and knee OA [4]. Low self-efficacy and helplessness have
also been identified as predictors of disability in OA
patients [14,15].
According to several reviews, psychological factors in-
fluence not only pain and disability, but also in particu-
lar the transition from the presence of acute to chronic
pain [13,16]. However, there have been relatively few
attempts to prevent chronic disability in OA by adopting
a CB approach. Calfas et al. conducted a randomizedcontrolled trial (RCT) testing a 10-week group-based CB
program on 40 OA patients [17]. They concluded that in
the long term, physical and psychological functioning
did not differ between the CB and the education control
group. In 2011, Riddle et al. published the results of a
quasi-experimental study testing an 8-session individual
pain coping skills training (PCST) program in patients
with elevated pain catastrophizing who were scheduled
for knee arthroplasty [18]. They found that the PCST
program resulted in significantly greater reductions in
pain severity and catastrophizing, and greater improve-
ments in function when compared with the usual care
cohort. Somers et al. recently reported the results of an
RCT studying the effects of a PCST program and a
behavioral weight management intervention [19]. They
concluded that the combination of these two treatments
yielded significantly better outcomes in terms of pain,
physical disability, stiffness, activity, arthritis self-efficacy,
and weight self-efficacy than either of the intervention
modalities alone or that evident in the control group.
There are several trials that have used behavioral inter-
ventions with similarities to CB principles as well as
studies that have integrated CB principles with other
forms of rehabilitation in OA patients. For example,
Hurley et al. conducted an RCT assessing the effects of a
combined exercise, self-management, and active coping
strategies rehabilitation program [20]. They found over
the long-term, that the rehabilitated participants enjoyed
better physical function, lower community-based health
care costs, medication costs, and total health and social
care costs as well as concluding that there was a high
probability (80–100%) that the program was cost effect-
ive. On the other hand, Keefe et al., adopted an RCT
setting to investigate the separate and combined effects
of spouse-assisted pain coping skills training and exer-
cise training in patients having persistent osteoarthritic
knee pain [21]. They concluded that the kind of in-
tervention combining spouse-assisted coping skills train-
ing and exercise training could improve physical fitness,
strength, pain coping, and self-efficacy in patients suffer-
ing from pain due to OA.
One CB-based approach in treating pain-related dis-
ability and chronicity is the 6-session group intervention
model presented by Linton [22]. The model was ori-
ginally developed for early identification and interven-
tion in the prevention of musculoskeletal pain [23,24].
The standardized 6-session program focused on coping,
function and cognitions and the application of learning
principles to allow the individual to utilize more adaptive
methods of pain management and active coping [22].
The model has previously been tested in RCT setting in
patients with back and neck pain [23-25]. In these stud-
ies, the CB intervention led to less short- and long-term
work absenteeism, fewer health care visits, decreased
Table 1 Inclusion and exclusion criteria
Inclusion criteria:
1. Age 35–75 years
2. Pain within the last year in or around the knee occurring on
most days for at least a month [27]
3. Knee pain greater than or equal to 40 mm on a 100-mm visual
analogue scale (VAS) in the WOMAC* [28-31] pain subscale for
one week prior to study entry
4. KL** 2–4 [32] radiographic knee osteoarthritis
5. Able to attend 6 intervention sessions
Exclusion criteria:
1. Severe psychiatric or psychological disorder***
2. Other back or lower limb pain symptoms more aggravating than
knee pain
3. Previous or planned lower extremity joint surgery
4. Inability to complete the study ****
*Western Ontario and McMaster Universities Osteoarthritis Index.
**Kellgren–Lawrence radiologic score for knee osteoarthritis.
***Psychotic illnesses or psychological disorders that had led to hospitalization
or disability to work.
**** Inability to fill in the questionnaires or uncertainty in ability to complete
the study due to possible changes in the near future related to health, family,
or living conditions.
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number of pain-free days.
The present study aims to explore the effectiveness
and cost-effectiveness of the CB group intervention
described by Linton [22], modified for patients with knee
OA. As far as we are aware, there have been no previous
studies using this approach in patients with knee OA.
The working hypothesis is that patients with symptom-
atic knee OA will benefit from this kind of CB rehabili-
tation program. More specifically, we intend to examine
the effect of the intervention in terms of self-reported
physical function and pain, pain-related work abstinence,
the number of pain-related health care visits, and health-
related quality of life (HRQoL). We also aim to determine
the effect of the intervention on several psychological vari-
ables such as depression, anxiety, sense of coherence, pain
catastrophizing, kinesiophobia, self-efficacy, and life satis-
faction. Finally, we plan to run a cost-utility analysis of the
intervention based on quality-adjusted life years (QALY).
Methods/Design
Design
The proposed research is a 6-week open study with
follow-up-points at 3 and 12 months from the beginning
of the study. The participants will take part in 6 group
meetings each lasting 2 hours. The meetings will be
supervised by a trained psychologist and a physiotherap-
ist according to a CB intervention model presented by
Linton [22]. At the beginning of the study, prior to the
randomization, all the patients will participate in groups
of about 20 people to hear a lecture regarding the current
treatment guidelines for knee OA provided by the study
doctors. They will also receive the patient-version booklet
of the Finnish Current Care (CC) guideline on knee and
hip OA [26]. The study protocol does not interfere with
the usual care that the participants may receive from their
general practitioner (GP) in primary health care during
the study period. Questionnaires will be sent to all partici-
pants at the beginning of the study and at two follow-up
points (3 and 12 months). The inclusion and exclusion
criteria for the study patients are listed in Table 1. The
study design is illustrated in Figure 1.
Participants and recruitment
Our aim is to recruit 108 patients mainly from primary
care providers in the Kuopio area of eastern Finland.
Our primary recruitment strategy is to dispatch recruit-
ment letters to patients aged from 35 to 75 years who
have had knee radiographs with knee OA changes taken
in public primary care locations (Kuopio Health Centre
or Kallaveden Työterveys). The study doctors will check
the knee radiographs of each patient from an X-ray data-
base and knee radiographs will be graded according to the
Kellgren-Lawrence (KL) classification [32]. The recruitmentletter will be sent to those subjects with KL grade ≥2, which
has been used as a cut-off to classify knee OA [33]. In
conjunction with this recruitment strategy, advertisements
requesting potential study candidates to contact the study
doctors will be placed in the facilities of local primary care
providers as well as in the outpatient clinics of the Depart-
ment of Orthopedics and the Department of Physical
and Rehabilitation Medicine at Kuopio University Hospital.
Physicians and surgeons working at these locations will also
be informed about the study and asked to distribute the
advertisements to patients with knee OA.
All study candidates will receive a recruitment letter
containing information about the study as well as a pre-
liminary questionnaire and an informed consent form.
The preliminary questionnaire will contain a compre-
hensive list of other comorbidities, including psychiatric
illnesses. In the preliminary questionnaire the patients
will be asked if they have other back or lower limb pain
symptoms that are more aggravating than their knee
pain (yes/no). After receiving the signed informed con-
sent and the questionnaire, the study doctors will check
the knee radiographs based on KL classification and
determine the patient’s eligibility according to the inclu-
sion and exclusion criteria of the study (Table 1). Poten-
tial study patients will be able to contact the study
doctors by phone or email throughout the recruitment
process with any questions concerning the trial.
The patients will be randomly assigned to either the
GP care and intervention group (n = 54) or the GP care
control group (n = 54). Randomization will be con-
ducted in blocks of six, separately for men and women.
A computer-generated code for randomization will be
Figure 1 The study design. GP = general practitioner; CB = cognitive-behavioral; WOMAC = Western Ontario and McMaster Osteoarthritis Index;
RAND-36 = the RAND 36-item health survey; 15D = generic 15D instrument; BDI-21 = 21-item Beck Depression Inventory; BAI = Beck Anxiety
Index; TSK = Tampa Scale for Kinesiophobia; PCS = Pain Catastrophizing Scale; PSEQ = Pain Self-Efficacy Questionnaire; LS = life satisfaction;
SOC = sense of coherence; GAC = global assessment of change.
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patients, and it will be administered via sealed opaque
envelopes. The personnel responsible for data collection
will be blinded to group assignment and will not be
involved in providing the interventions. The code for
randomization will be opened only after the statistical
analyses have been performed after the 12-month fol-
low-up point.
Intervention
A CB group intervention with 6 weekly sessions will be
supervised by an experienced psychologist and a physio-
therapist. The sessions will take place in a group of 8–10
persons according to the model presented by Linton [22].
Each session will last for 2 hours with a 15–20-minute
break to enhance peer support and social bonding. The
outline of the sessions will include an introduction
(15 min), lecture (knowledge and insight, max 15 min),problem solving (in pairs/teams, 15–20 min), skills train-
ing (15–20 min), homework assignments (15 min) and a
résumé (feedback) of the session (15 min). A patient
example of a knee OA pain patient will be used through-
out the intervention as a basis for discussion and practice
in problem solving. An outline of each session is presented
in Table 2. The psychologist is the principal leader of the
CB intervention. The physiotherapist’s tasks are to lead
the relaxation exercises, provide the information of OA
pain mechanisms in the first session, offer advice about
suitable exercises in the second session, and facilitate the
group in general when needed. Both the intervention and
the control group will continue side by side with the usual
GP care that patients may receive in the primary care
throughout the study.
The same psychologist and physiotherapist who are
both experienced in group-based rehabilitation interven-
tions as well as in pain management will arrange the CB
Table 2 An overview of the content of the cognitive-behavioral intervention based on Linton (2005) [22]
Session Focus Skills Objectives
1 Causes of pain and the
prevention of chronic problems
Problem solving •To provide information about the causes of pain.
Applied relaxation •To provide information about the risk of chronic pain problems.
Learning and pain •To help participants in identifying relevant factors in one’s own pain
problem.
•To train problem-solving and relaxation skills.
•To teach pain control techniques.
2 Managing your pain Activities, maintain daily
routines
•To provide information about the relationship between activity and
musculoskeletal pain.
Scheduling activities
Relaxation training •To help participants in understanding fear avoidance behavior.
•To teach participants to identify goals for a satisfying activity level.
•To teach management skills: scheduling, pacing, graded increase.
•To teach cognitive skills to minimize problems with activities.
•To introduce stress and stress management.
3 Promoting good health, controlling
stress at home and at work
Warning signals •To provide information how pain problems may be prevented.
Cognitive appraisal •To provide information how to utilize thoughts and behaviors in
preventive efforts.
Beliefs •To teach how to apply various skills (relaxation, activity
management, beliefs, pauses etc.) as coping.
•To help the participants to identify targets for developing coping
strategies.
•To teach applied relaxation as coping strategies.
4 Adapting for leisure and work Communication skills •To provide opportunities to receive reinforcement for correct
”coping” approximations from the group.
Assertiveness
Risk situations •To provide information about how workplace and family may be
influenced by the participant’s pain problem.
Applying relaxation
•To provide information and coping strategies concerning situations
where the workplace and family may influence the participant’s pain
perceptions.
•To teach assertiveness in using the coping skills learnt.
•To help participants to identify supportive behaviors from others.
•To teach participants to prompt these behaviors to promote
positive relationships with family and friends.
•To teach how to apply rapid relaxation to risk situations.
•To teach participants how to employ several coping techniques in
social situations.
•To begin to plan a personal coping program.
5 Controlling flare-ups Plan for coping and flare-ups •To provide information about flare-ups and maintenance.
Coping skills review •To teach how to use applied relaxation as coping.
Applied relaxation •To teach how to apply their skills to cope with flare-ups.
Own program •To develop a personalized coping program.
•To develop a self-care strategy that may reduce the need for
healthcare visits.
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Table 2 An overview of the content of the cognitive-behavioral intervention based on Linton (2005) [22] (Continued)
6 Maintaining and improving results Risk analysis •To reinforce appropriate coping behaviors.
Plan for adherence •To provide information about maintenance and adherence.
Own program finalized •To teach participants to do risk analysis and enhance adherence.
•To teach participants about enhancing and fine-tuning their
program.
•To evaluate the course and participants’ progress.
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trained for this particular CB intervention by going
through in detail the session manual for therapists [22]
and its Finnish translated version together with the other
members of the research group.Outcome assessment
The assessment points of this study are the baseline and
3 and 12 months, at which time points the question-
naires will be sent by post to the patients with a pre-
paid return envelope. At the baseline, information will
be gathered on the demographics, comorbidities, work
history, and previous rehabilitation measures. The pri-
mary and secondary outcomes and other measures are
listed in Table 3.
The primary outcome measure of the study is the
Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) self-reported pain subscale [28,29],
which is to be measured with the pain subscale of the
Finnish version of the WOMAC [30,31]. The Finnish
WOMAC consists of three dimensions: pain (5 items),
stiffness (2 items), and physical functioning (17 items).Table 3 Outcomes and other measures
Primary outcome measure*
Self-reported pain WOM
Secondary outcome measure* Meas
Self-reported physical function, pain and stiffness WOM
and w
Depression, anxiety, sense of coherence, pain catastrophizing,
kinesiophobia, self-efficacy, and life satisfaction
BDI-2
PSEQ




Identifying risk for persistent pain Öreb
Major life events Open
Adherence Atten
*The primary end point for data analysis is 12 months. All outcome measures will b
Ontario and McMaster Osteoarthritis Index; NPRS = numeric pain rating scale; BDI-2
of coherence; PCS = Pain Catastrophizing Scale; TSK = Tampa Scale for Kinesiophob
the RAND 36-item health survey; 15D = generic 15D instrument; QALY = quality-ad
MPQ = Musculoskeletal Pain Questionnaire.Responses for the 24 items are registered on a 0–100 mm
visual analogue scale (VAS).
Secondary outcomes of the study will include WOMAC
stiffness and physical function subscales [28-31], as well as
numeric pain rating scales of the worst and mean pain
during the previous week and past three months. The
health-related quality of life will be evaluated with 15D
[58] and RAND-36 [56,57]. The use of pain medication,
the number of knee OA-related health care visits, sick
leave days, rehabilitation and pensions will be recorded.
The patients will also be asked to complete several psy-
chological questionnaires at the assessment points: de-
pression will be evaluated with Beck's Depression
Inventory (BDI-21) [34-37], anxiety with Beck's Anxiety
Index (BAI) [38,39], sense of coherence with a 13-item
sense of coherence scale (SOC) [40-46], catastrophizing
with the Pain Catastrophizing Scale (PCS) [47,48], kinesio-
phobia with Tampa Scale of Kinesiophobia (TSK) [49,50],
pain self-efficacy with Pain Self-Efficacy Questionnaire
(PSEQ) [51,52], and life satisfaction (LS) with a 4-item LS
scale [53-55]. Finally, some questions concerning major
life events and the global assessment of change will be
included.AC (VAS) [28-31] pain subscale
urement
AC (VAS) physical function and stiffness subscales [28-31], NPRS, mean
orst pain (past week, 3 months)
1 [34-37], BAI [38,39], 13-item SOC scale [40-46], PCS [47,48], TSK [49,50],
[51,52], 4-item LS scale [53-55]
-36 (SF-36) [56,57], 15D [58], QALY [58], OA-related sick leave, use of pain





e undertaken at baseline and after 3 and 12 months. WOMAC = Western
1 = 21-item Beck Depression Inventory; BAI = Beck Anxiety Index; SOC = sense
ia; PSEQ = Pain Self-Efficacy Questionnaire; LS = life satisfaction; RAND-36 =
justed life years; OA = osteoarthritis; GAC = global assessment of change;
Helminen et al. BMC Musculoskeletal Disorders 2013, 14:46 Page 7 of 10
http://www.biomedcentral.com/1471-2474/14/46Statistical analysis
The mean (±SD) knee joint pain score (WOMAC, VAS)
was estimated by using the results of the knee joint pain
scores in previous studies [60,61]. Since the knee pain
has to be ≥40 mm on a 100-mm VAS (WOMAC) in this
present study, we postulated that there will be a mean of
at least 48±16.2 mm in the WOMAC pain subscale at
baseline. In our study the 20% reduction in primary out-
come (WOMAC pain) due to the intervention was con-
sidered as being clinically relevant in accordance with
the OMERACT-OARSI set of responder criteria [62]. In
the comparison of the mean pain scores between the
groups, 54 patients per group are needed according to a
power calculation with the two-tailed Student t-test with
a 5% significance level and 80% power, assuming a 20%
dropout rate [63].
Demographic characteristics and baseline data will be
summarized by descriptive statistics. Randomly missing
data in the longitudinal set-up will be imputed using
expectation–maximization algorithm before the analysis
in order to follow the intention to treat principle. Data
on various psychological variables predicting reported
knee pain will be assessed by multiple regression analysis.
For outcomes measured on a continuous scale, differences
between groups in the mean change from the baseline to
12 months will be evaluated using the linear mixed model-
ing. The model assumptions will be checked by standard
diagnostic plots. The participant rating of the global as-
sessment of change will be compared between the two
groups using the two-tailed Student t-test.
Cost-effectiveness of the intervention will be evaluated
by cost-utility analysis which is a techniques that incorpo-
rates the expenses of the intervention as well as the costs
of the use of health care services and pain medication, sick
leaves, rehabilitation and pensions. Utility analysis is based
on measurement of QALY from 15D [58]. Life expectancy
with 0%, 3% and 5% discounting will be incorporated in
the analysis. The cost-effectiveness of the intervention can
be evaluated by dividing the overall costs with the QALY.Discussion
There are several reasons why this study will advance
our understanding of effective interventions to improve
conservative knee OA treatment. First, there have only
been a few studies evaluating the effect of psychologi-
cal interventions on knee OA pain. Thus, good quality
RCTs are needed to determine their effectiveness. As
present, very few studies have evaluated a CB inter-
vention for knee pain treatment, as far as we are aware
this will be the first study to tackle this particular CB
intervention model in treating OA patients. Second, the
proposed research will address the very current topic
of non-pharmacological conservative treatment of kneeOA, and the results may have a significant impact on
current care recommendations. Since knee OA is the
most common form of arthritis, representing a major
economic burden on social welfare and healthcare systems
for both society and individual patients, it is worthwhile to
find novel cost-effective interventions promoting conser-
vative treatment. Third, it is important to evaluate this
kind of CB intervention since cognitive and psychological
factors are known to play major roles in chronic pain, pain
severity and disability. Moreover, evidence-based guide-
lines indicate that one should adopt a the combination
of pharmacologic and nonpharmacologic modalities to
achieve adequate management of knee OA [64-66]. With
respect to nonpharmacologic treatment modalities, it has
been occasionally recommended that patients should par-
ticipate in self-management programs with psychosocial
interventions [64]. We hope that the results of the cost-
effectiveness and cost-utility analysis of the proposed study
will favour their inclusion into the current care recommen-
dations in the future.
The study protocol has some limitations. First, due to
volunteer bias, the results of psychological intervention
studies may have limited generalizability [67]. Second, as
the majority of the study patients will probably originate
from primary care, the results of this study will mainly
apply to that environment. Third, the CB protocol pre-
sented by Linton [22] indicates that patients participat-
ing in a CB-type intervention should be evaluated to
ensure that they are at risk of developing a persistent
pain problem. Linton himself has developed a question-
naire, the Örebro Musculoskeletal Pain Questionnaire
(MPQ) [59], to be used for this purpose. In our study,
however, we have decided not use this questionnaire or
any other cognitive or psychological evaluation as part
of the inclusion criteria. One reason for this decision is
that the Örebro MPQ has only been validated in back
pain patients, and there is a lack of data concerning the
similarity of pain experiences in back and knee OA pain
in general. Furthermore, our inclusion criteria already
include several pain measures, assessing both intensity
and duration of pain. We consider that by applying to
these criteria, in all probability, the patients would be at
risk of developing a persistent pain problem if they were
not already suffering from it. However, the Örebro MPQ
will be included in the baseline patient questionnaire for
analysis purposes. With the availability of the final data
of the study, it will be interesting to see whether those
patients determined to be at risk of developing a persistent
pain problem according to the Örebro MPQ have bene-
fited more from this intervention.
Another limitation of the study might be the different
amount of attention paid to the two groups. As the group
of patients in the intervention will receive 12 hours more
attention, a Hawthorne effect [68-70] is probable.
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tions about knee OA treatment according to Finnish CC
guideline [26] when they are listening to a lecture deliv-
ered by a general practitioner prior to the randomization.
This lecture will be held in groups of about 20 people and
the whole research group will be present to answer ques-
tions. During the lecture the patient-version booklet of
Finnish CC guideline on knee and hip OA [26] will be
handed out to all participants. The participants in both
groups also will continue to receive standard care (i.e. nor-
mal routine care offered by their own general practitioners
including analgesics and physiotherapy).
BDI-21, BAI, 13-item SOC scale, TSK, PSEQ and LS
questionnaires have been used in several clinical studies
in Finland [35-37,39,44-46,50,52-55]. However, at pre-
sent BDI-21 and 13-item SOC scales have been validated
in Finland [37,46] and the validation process of TSK is
almost complete. We have available translated versions
of separate questionnaires that have been in use in
clinical studies and clinical routine in Finland. As the
psychometric questionnaires are all secondary outcome
measures in our study we decided to include them even
though there is a shortage of supporting evidence for the
validity of some of their psychometric measurement
properties in Finnish patients.
Obtaining and assessing KL grades are not simple tasks.
Valid measures are dependent on knee flexed standing
views [71,72] and examiner experience [73,74]. Although
it has recognized weaknesses, the KL score has been the
most widely used radiographic score to assess knee OA
[73]. We decided to use KL grade ≥2, which has been
extensively used as the inclusion criterion in knee OA
studies [33]. Unfortunately, we will not be able to control
the radiographic quality since the knee X-rays will have
been taken in public primary care locations and in the
outpatient clinics. However, we use the combined radio-
graphic and clinical criteria that have been proposed for
use when diagnosing knee OA. If one combines the
clinical and radiographic factors, the sensitivity and spe-
cificity of knee OA diagnosis are 91% and 86%, respect-
ively [75]. The observers also will be well trained and
acquainted with the radiographic atlas of the KL scores
before the start any assessments. Although reliability for
the separate KL radiographic features may depend on the
level of the investigator’s experience, the intra- and inter-
observer reliability for the overall score is known to be
relatively high [74].
No significant side effects or adverse events are expected.
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